Refine by:
-
NAMI Seeks Participants for Survey on Lived Experience of Borderline Personality Disorder
NAMI is conducting a Virtual Advisory Panel — an online platform for participants to anonymously answer a survey on how Borderline Personality Disorder (BPD) affects their life, work and relationships. -
Letter to HHS Secretary on Treatment Innovation
Letter to HHS Acting Secretary Cochran, urging the withdrawal of the proposed rule on extramural research involving human fetal tissue. -
Letter to President Biden on Treatment Innovation
Letter to President Biden, urging to rescind the human fetal tissue research restrictions and policy changes that the Department of Health and Human Services made in 2019. -
NAMI Hosting Free, Virtual Inspiring Hope Through Research Event
This year’s award honoree, Dr. David C. Henderson, is the Psychiatrist-in-Chief at Boston Medical Center and Professor and Chair of Psychiatry at Boston University School of Medicine. -
Register for NAMI’s Ask the Expert Webinar: New Horizons in Schizophrenia Research
Register for NAMI's Ask the Expert Webinar: New Horizons in Schizophrenia Research on Thursday, October 8, 2020 at 4:00 p.m. ET. -
Congress Passes New Bill to Improve Veterans’ Mental Health Care
On Wednesday, September 23, 2020, NAMI celebrated the U.S. House of Representatives’ unanimous passage of a landmark bipartisan bill, S. 785, The Commander John Scott Hannon Veterans Mental Health Care Improvement Act. -
NAMI Applauds Victory for Veterans’ Mental Health
Today, the U.S. House of Representatives unanimously passed a landmark bipartisan bill, S. 785, The Commander John Scott Hannon Veterans Mental Health Care Improvement Act, which previously passed the Senate. -
A New Treatment Option for Major Depressive Disorder
Esketamine has been shown to reduce symptoms within 24 hours, offering game-changing hope for adults in need of immediate relief. -
NAMI Joins Public–Private Partnership to Advance Early Interventions for Schizophrenia
Today, NAMI announced it has joined the Accelerating Medicines Partnership (AMP) Schizophrenia (SCZ), which brings together NIH, the U.S. Food and Drug Administration and multiple non-profit and private organizations to work toward meeting the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. -
Register for NAMI’s Ask the Expert Webinar: Eating for Better Mental Health
Register for NAMI's Ask the Expert Webinar: Eating for Better Mental Health on Thursday, September 10, 2020 at 4:00 p.m. ET.